| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 9,570 | $30 | $248.8K |
| Q5103 | Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg | 9,630 | $20 | $144.5K |
| J0897 | Injection, denosumab, 1 mg | 5,160 | $20 | $92.9K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 5,930 | $10 | $65.2K |
| Q5121 | Injection, infliximab-axxq, biosimilar, (avsola), 10 mg | 1,960 | $20 | $43.1K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 400 | $90 | $36.3K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 290 | $100 | $27.9K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 310 | $60 | $19.3K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 150 | $50 | $7.7K |
| 96415 | In this add on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report each additional hour of infusion beyond the… | 290 | $20 | $6.3K |